首页 > 市场调查报告书 > 医疗设备

导管

生物可吸收支架市场规模、份额和成长分析（按材料类型、应用、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1897595

生物可吸收支架市场规模、份额和成长分析（按材料类型、应用、最终用户和地区划分）—2026-2033年产业预测

Bioresorbable Scaffolds Market Size, Share, and Growth Analysis, By Material Type (Polymer-based Scaffolds, Metallic Scaffolds), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，生物可吸收支架市场规模将达到 20.4 亿美元，到 2025 年将达到 24.4 亿美元，到 2033 年将达到 101.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 19.5%。

由于医疗技术的进步和心血管疾病盛行率的迅速上升，生物可吸收支架市场正经历强劲成长。这些临时植入会随着时间的推移而逐渐溶解，从而促进血管的自然癒合。该市场按材料类型、应用、最终用户和地区进行细分。聚合物基支架因其良好的生物相容性和可吸收性主导主导地位，其中心血管疾病的需求量最大。医院、门诊手术中心和专科诊所是主要的最终用户，这主要得益于接受介入性心臟病手术的住院患者数量的增加。北美凭藉其先进的医疗基础设施占据了较大的市场份额，其次是欧洲的研究倡议和亚太地区不断增长的投资。儘管面临高成本等挑战，但持续的研发预计将支撑未来的市场成长。

生物可吸收支架市场驱动因素

心血管疾病（包括冠状动脉疾病和周边动脉疾病）发生率的不断上升是生物可吸收支架市场成长的主要驱动力。随着这些健康问题的日益普遍，迫切需要能够恢復正常血液循环的有效治疗方法。这种不断增长的需求正在推动创新医疗解决方案的研发，尤其是生物可吸收支架，它们在治疗这些复杂的心血管疾病方面展现出良好的前景。不断寻求针对这些常见疾病的更有效治疗方法是推动生物可吸收支架市场发展的根本因素。

生物可吸收支架市场受到抑制

由于缺乏长期临床证据，生物可吸收支架市场面临许多挑战。亟需进行全面的评估，比较生物可吸收支架植入与传统支架的性能。若缺乏这项关键评估，则难以最终确定生物可吸收支架的有效性和安全性。缺乏可靠的临床数据阻碍了市场成长，因为除非有明确证据表明其优于传统方案，否则医疗机构可能不愿意采用这些创新解决方案。因此，解决这个问题对于生物可吸收支架市场的未来发展至关重要。

生物可吸收支架市场趋势

生物可吸收支架的需求正呈现显着上升趋势，这主要得益于日益增长的老龄人口对先进医疗解决方案的需求。随着老年人更容易罹患心血管疾病，对有效且创新治疗方法的需求也日益增加。生物可吸收支架因其在治疗后可被人体自然吸收的特性而备受青睐，可望减少与永久性装置相关的长期併发症。这种向微创、临时性解决方案的转变代表了医疗保健领域的一个更广泛趋势，体现了医疗服务提供者在满足老年患者特殊需求的同时，不断努力改善患者疗效的决心。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Medtronic plc（Ireland）
Terumo Corporation（Japan）
Biotronik SE & Co. KG（Germany）
REVA Medical, Inc.（USA）
Elixir Medical Corporation（USA）
Amaranth Medical, Inc.（USA）
Arterial Remodeling Technologies（France）
Meril Life Sciences Pvt. Ltd.（India）
Kyoto Medical Planning Co., Ltd.（Japan）
Lepu Medical Technology（Beijing）Co., Ltd.（China）
S3V Vascular Technologies（India）
Zorion Medical（USA）
ICON Interventional Systems（USA）
Xenogenics Corporation（USA）
Arterius Limited（UK）
SMT（Sahajanand Medical Technologies）（India）
B. Braun Melsungen AG（Germany）
Cardionovum GmbH（Germany）

结论与建议

简介目录

Product Code: SQMIG35A2472

Bioresorbable Scaffolds Market size was valued at USD 2.04 Billion in 2024 and is poised to grow from USD 2.44 Billion in 2025 to USD 10.14 Billion by 2033, growing at a CAGR of 19.5% during the forecast period (2026-2033).

The bioresorbable scaffolds market is experiencing robust growth driven by advancements in medical technology and a surge in cardiovascular disease prevalence. These temporary implants promote natural vessel healing by gradually dissolving over time, with the market segmented into material type, application, end-user, and region. Polymer-based scaffolds lead due to their biocompatibility and resorption characteristics, while applications are primarily centered on cardiovascular diseases, which dominate demand. Hospitals, ambulatory surgical centers, and specialized clinics serve as key end-users, fueled by increasing cardiac intervention admissions. North America holds a significant share, supported by advanced healthcare infrastructure, followed by Europe's research initiatives and the Asia-Pacific region's growing investments. Although challenges like high costs exist, ongoing research is expected to bolster market growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioresorbable Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioresorbable Scaffolds Market Segments Analysis

Global Bioresorbable Scaffolds Market is segmented by Material Type, Application, End-user and region. Based on Material Type, the market is segmented into Polymer-based Scaffolds and Metallic Scaffolds. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Cardiac Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioresorbable Scaffolds Market

The increasing incidence of cardiovascular conditions, including coronary artery disease and peripheral artery disease, significantly fuels the growth of the bioresorbable scaffolds market. As these health issues become more common, there is an urgent need for effective treatment options that can restore proper blood flow. This rising demand encourages the development of innovative medical solutions, particularly bioresorbable scaffolds, which offer promising results in managing these complex cardiovascular conditions. The continuous search for improved therapeutic approaches in the face of these prevalent disorders is thus a fundamental factor driving the bioresorbable scaffolds market forward.

Restraints in the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market encounters significant obstacles due to a scarcity of long-term clinical evidence. There is a pressing need for comprehensive assessments comparing the performance of bioresorbable scaffold implants with that of conventional stents. Without this crucial evaluation, it remains difficult to definitively establish the efficacy and safety of bioresorbable scaffolds. This lack of robust clinical data hinders the market's growth, as healthcare providers may be hesitant to adopt these innovative solutions without clear evidence of their advantages over traditional options. Consequently, addressing this issue is vital for the future advancement of the bioresorbable scaffolds market.

Market Trends of the Bioresorbable Scaffolds Market

The demand for bioresorbable scaffolds is witnessing a significant upward trend, largely propelled by the rise of the geriatric population, which necessitates enhanced healthcare solutions. As older individuals become more prone to cardiovascular diseases, the requirement for effective and innovative treatment options intensifies. Bioresorbable scaffolds, known for their ability to dissolve within the body post-treatment, are increasingly favored for their potential to reduce long-term complications associated with permanent devices. This shift towards less invasive, temporary solutions reflects a broader movement in healthcare, as providers aim to meet the unique needs of aging patients while continually improving patient outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Bioresorbable Scaffolds Market Size by Material Type & CAGR (2026-2033)

Market Overview
Polymer-based Scaffolds
Metallic Scaffolds

Global Bioresorbable Scaffolds Market Size by Application & CAGR (2026-2033)

Market Overview
Coronary Artery Disease
Peripheral Artery Disease

Global Bioresorbable Scaffolds Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

Global Bioresorbable Scaffolds Market Size & CAGR (2026-2033)

North America (Material Type, Application, End-user)
- US
- Canada
Europe (Material Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Material Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Material Type, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Material Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
REVA Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elixir Medical Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amaranth Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arterial Remodeling Technologies (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyoto Medical Planning Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology (Beijing) Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
S3V Vascular Technologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zorion Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON Interventional Systems (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xenogenics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arterius Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMT (Sahajanand Medical Technologies) (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardionovum GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments